Sanofi
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SNW.DE | BIIB | PFE | NVS | GILD | AZN | |
|---|---|---|---|---|---|---|
| Market cap | 88.26B | 35.92B | 171.62B | 292.03B | 194.07B | 261.82B |
| P/E (TTM) | 22.7 | 43.2 | 39.6 | 23.2 | — | 25.2 |
| Forward P/E | 10.4 | 14.8 | 10.4 | 15.7 | 15.7 | 14.9 |
| Price/book | 1.3 | 1.9 | 2.0 | 7.0 | 16.4 | 5.2 |
| Dividend yield | 5.60% | — | 5.71% | 3.09% | 2.10% | 1.90% |
| 1-year change | −17.79% | +64.57% | +21.80% | +16.90% | +28.86% | +1.43% |
| Today | +0.12% | +4.12% | +2.28% | +2.29% | +2.25% | +2.97% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All SNW.DE news ›Sanofi breaks ground on new insulin manufacturing facility in Germany
Sanofi breaks ground on a new Frankfurt insulin plant, boosting global supply. Panama7/iStock Editorial via Getty Images - Sanofi (SNY) has broken ground on a new insulin manufacturing facility at its BioCampus in Frankfurt, Germany, with…
RXRX Stock Pops As Sanofi Deal And ARK Buying Fuel AI-Drug Hype
Recursion Pharmaceuticals Inc. stocks have been trading up by 4.26 percent following optimism over its latest AI-driven drug discovery advances. RXRX has been on a wild ride in October. The daily chart shows Recursion Pharmaceuticals…
Sanofi : UBS sticks Neutral
Published on 10/15/2026 at 08:25 am EDT Sanofi to invest up to $8bn to expand alliance with Regeneron October 01, 2026 at 05:58 am EDT Sanofi: Q2 beat gets sidelined by burning pipeline issues Sanofi prepares for the future and once again…
Sanofi : Gets a Neutral rating from RBC
Published on 10/16/2026 at 02:41 am EDT Sanofi to invest up to $8bn to expand alliance with Regeneron October 01, 2026 at 05:58 am EDT Sanofi: Q2 beat gets sidelined by burning pipeline issues Sanofi prepares for the future and once again…
Sanofi $SNY Stake Raised by First Bank & Trust
First Bank & Trust increased its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 16.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund…
European Commission Accepts Sanofi's Commitments Over Alleged 'Disparagement Campaigns' Against Efluelda Rival
Published on 10/14/2026 at 06:11 am EDT Sanofi to invest up to $8bn to expand alliance with Regeneron October 01, 2026 at 05:58 am EDT Sanofi: Q2 beat gets sidelined by burning pipeline issues Sanofi prepares for the future and once again…
RBC Cuts Price Target on Sanofi to EUR75 From EUR80, Keeps Sector Perform Rating
Published on 10/16/2026 at 07:37 am EDT Sanofi to invest up to $8bn to expand alliance with Regeneron October 01, 2026 at 05:58 am EDT Sanofi: Q2 beat gets sidelined by burning pipeline issues Sanofi prepares for the future and once again…
Sanofi Signs Letter of Intent with Pan-Canadian Pharmaceutical Alliance for Dupixent Across Four Indications in Dermatology and Respiratory Care
Published on 10/15/2026 at 12:00 pm EDT Sanofi and pan-Canadian Pharmaceutical Alliance signed Letter of Intent for Dupixent® Across Four Indications in Dermatology and Respiratory Care. Sanofi to work with provinces, territories, and…
Sanofi takes over the Tour de France white jersey as Castelli returns as kit supplier
CyclingUpToDate.com Sanofi takes over the Tour de France white jersey as Castelli returns as kit supplier Tour's symbol since the 1970s From Moser, through Pogacar, to Del Toro Tour of Guangxi 2026 stage 6 preview, profiles, favourites &…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com16
-
seekingalpha.com10
-
markets.businessinsider.com5
-
firstwordpharma.com4
-
statnews.com4
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.